| Serial Number | 97700225 |
| Word Mark | KANO THERAPEUTICS |
| Filing Date | Thursday, December 1, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, September 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 23, 2024 |
| Goods and Services | Custom manufacturing of nucleic acids for diagnostic, medical and commercial applications in relation to cell and gene therapies; Custom manufacturing of nucleic acids, biological organisms and components and products thereof in the nature of therapeutics for pharmaceutical drug development; Manufacturing services for others, namely, manufacture of synthetic DNA and genes; Custom manufacturing, namely, synthesis of pharmaceuticals |
| Goods and Services | Pharmaceutical preparations for single-stranded DNA; Biologics, namely, nucleic acids for use as therapeutics for clinical and medical use |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Pharmaceutical drug development services; Scientific research and development of synthesis of pharmaceuticals; Scientific research and development; Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Biochemical research and development services, namely, custom development and synthesis of nucleic acids, biological organisms, and components and products thereof for pharmaceutical drug development; Design and development in the field of custom synthesis of cells and vectors for diagnostic, medical and commercial applications in relation to the design of nucleic acids and genetic medicines; Bioinformatic design of genetically engineered organisms; Research, design, and development of genetically engineered organisms; Product development consultation in the fields of pharmaceutical, medical, scientific, and biopharmaceutical research and development; Product development in the fields of products for pharmaceutical drug development; Research and development in the field of pharmaceuticals; Research and design services relating to pharmaceuticals; Research in the field of pharmaceutical preparations |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 28, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 28, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 28, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kano Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Kano Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Monday, December 5, 2022 | NEW APPLICATION ENTERED |
| Wednesday, December 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 22, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, March 22, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, March 22, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, March 22, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, September 11, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, September 13, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 13, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 13, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 19, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 23, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, September 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, September 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 16, 2024 | SOU EXTENSION 1 FILED |
| Monday, September 16, 2024 | SOU EXTENSION 1 GRANTED |